GO:0002718 regulation of cytokine production involved in immune response: Immune Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002718 describes any process that modulates the frequency, rate, or extent of cytokine production that contributes to an immune response.
• Cytokine production is controlled at transcriptional, post-transcriptional, and redox-sensitive checkpoints, allowing immune cells to tune inflammation.
• IL-10 is a central anti-inflammatory cytokine whose production is regulated by multiple immune cell types and is essential for limiting immunopathology.
• RNA-binding proteins such as the ZFP36 family destabilize cytokine mRNAs and act as post-transcriptional brakes on immune responses.
• Dysregulated cytokine production contributes to periodontal disease, hypertension, leishmaniasis, and severe viral infections.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of genes that regulate cytokine production in immune cells.
Description
GO:0002718, regulation of cytokine production involved in immune response, is a biological process that encompasses any mechanism modulating the frequency, rate, or extent of cytokine production during an immune response. Cytokines are secreted signaling proteins that coordinate innate and adaptive immunity, and their production must be tightly controlled to eliminate pathogens without causing collateral tissue damage. This GO term therefore captures a central node in immunology: the regulatory inputs that determine when, where, and how much cytokine is made. Researchers study GO:0002718 because failures in cytokine regulation underlie chronic inflammatory diseases, autoimmunity, and impaired pathogen clearance. For example, inflammatory and immune pathways involving cytokine production are central to the pathogenesis of periodontal disease, while innate immune responses in hypertension involve altered cytokine regulation. The term also intersects with infectious disease biology, as thrombopoiesis and cytokine regulation influence outcomes in leishmaniasis, and interleukin-21 production is regulated during viral infections. At the molecular level, redox regulation of the immune response modulates cytokine production through oxidative signaling, and post-transcriptional control by RNA-binding proteins such as ZFP36 family members provides a rapid brake on cytokine mRNA stability. Together, these layers make GO:0002718 a rich area for functional genomics and CRISPR-based perturbation studies.
regulation of cytokine production involved in immune response At A Glance
| GO ID | GO:0002718 |
|---|---|
| GO term | regulation of cytokine production involved in immune response |
| Ontology | biological_process |
| Synonym | regulation of cytokine biosynthetic process involved in immune response; regulation of cytokine production during immune response; regulation of cytokine secretion involved in immune response |
| Major function | Modulates the frequency, rate, or extent of cytokine production that contributes to an immune response |
| Biological context | Innate and adaptive immunity, inflammation, host defense, and immune homeostasis |
| Key regulatory layer | Transcriptional, post-transcriptional, and redox-sensitive control of cytokine gene expression |
| Representative cytokines | IL-10, IL-21, and other immune-modulatory cytokines |
| Disease relevance | Periodontal disease, hypertension, leishmaniasis, and viral infections |
What Is GO:0002718?
In our own words, GO:0002718 refers to any biological process that adjusts the frequency, rate, or extent of cytokine production specifically in the context of an immune response. It includes regulation of cytokine biosynthesis, secretion, and production during immune activation, and it covers both positive and negative regulatory inputs that shape the magnitude and duration of cytokine output.
Why Is regulation of cytokine production involved in immune response Important in Cell Biology?
GO:0002718 is important because cytokine production is the central communication system of immunity, and its dysregulation directly causes or exacerbates human disease. Inflammatory and immune pathways driven by cytokines are pathogenic in periodontal disease, and innate immune responses involving cytokine regulation contribute to hypertension. In infectious disease, cytokine regulation influences outcomes in leishmaniasis and viral infections. Understanding this process is therefore essential for identifying therapeutic targets and for interpreting how genetic variants or CRISPR edits alter immune function.
• Cytokine production must be tightly regulated to balance pathogen clearance and tissue protection.
• Redox regulation of immune responses directly modulates cytokine production and inflammation.
• IL-10 production by immune cells is a key anti-inflammatory checkpoint within GO:0002718.
• Post-transcriptional regulation by ZFP36 family proteins controls cytokine mRNA stability and inflammatory disease.
• Dysregulated cytokine production is a driver of periodontal disease pathogenesis.
• Innate immune responses in hypertension involve altered cytokine regulation.
• Cytokine regulation intersects with thrombopoiesis in leishmaniasis.
• Interleukin-21 production is regulated during viral infections and shapes antiviral immunity.
• Mitochondria influence immune response regulation during bacterial infection.
• CRISPR-based models allow causal dissection of cytokine regulatory networks in immune cells.
What Happens During regulation of cytokine production involved in immune response?
Immune activation and cytokine gene induction
In simple terms: When immune cells sense a threat, they switch on cytokine genes.
During an immune response, pattern recognition and cytokine receptor signaling activate transcription factors that induce cytokine gene expression. This step determines the initial burst of cytokine production and is modulated by redox-sensitive signaling pathways that influence immune cell activation. The magnitude of induction is a key parameter regulated by GO:0002718, because excessive or prolonged cytokine production can damage host tissues.
Transcriptional control of cytokine production
In simple terms: Specialized transcription factors decide how much cytokine mRNA is made.
Transcriptional regulation of cytokine genes is a core mechanism within GO:0002718. For IL-10, multiple transcription factors and signaling pathways converge to control its production in different immune cell types. This layer integrates signals from innate and adaptive immune receptors, allowing cytokine output to match the type and duration of the immune challenge.
Post-transcriptional regulation of cytokine mRNAs
In simple terms: After cytokine mRNA is made, RNA-binding proteins can stabilize or destroy it.
Post-transcriptional control is a major determinant of cytokine production. ZFP36 family RNA-binding proteins promote the degradation of cytokine mRNAs and thereby limit inflammatory responses. This mechanism acts as a rapid brake on cytokine output and is directly relevant to inflammatory diseases where this control is lost.
Secretion and extracellular cytokine availability
In simple terms: Cytokines must be released from cells to act on their targets.
Regulation of cytokine production involved in immune response also includes control of cytokine secretion. The GO synonyms explicitly include regulation of cytokine secretion involved in immune response, reflecting that the amount of cytokine available to target cells depends on both synthesis and release. Secretion control shapes the spatial and temporal distribution of cytokines during immune responses.
Feedback and resolution of cytokine production
In simple terms: Anti-inflammatory signals switch cytokine production back off.
Resolution of immune responses requires negative feedback that suppresses cytokine production. IL-10 is a key anti-inflammatory cytokine whose regulated production limits excessive inflammation and prevents immunopathology. This feedback loop is an integral part of GO:0002718 and is essential for restoring immune homeostasis after infection.
Key Genes Involved in GO:0002718 regulation of cytokine production involved in immune response
The following genes and proteins are experimentally implicated in the regulation of cytokine production involved in immune response, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL10 | Encodes the anti-inflammatory cytokine IL-10, whose production is tightly regulated in immune cells | Central to studies of immune suppression and resolution of inflammation |
| ZFP36 | RNA-binding protein that destabilizes cytokine mRNAs and limits inflammatory cytokine production | Key post-transcriptional regulator in inflammatory disease models |
| ZFP36L1 | ZFP36 family RNA-binding protein involved in post-transcriptional control of immune responses | Candidate for CRISPR knockout studies of cytokine mRNA stability |
| ZFP36L2 | ZFP36 family RNA-binding protein that contributes to regulation of cytokine production | Relevant to inflammatory disease and immune cell homeostasis |
| IL21 | Encodes interleukin-21, a cytokine whose production is regulated during viral infections | Target for studies of antiviral immunity and cytokine regulation |
| NFKB1 | Transcription factor involved in immune and inflammatory signaling that influences cytokine production | Relevant to periodontal disease and inflammatory pathways |
| NFKB2 | Transcription factor contributing to immune pathway regulation and cytokine gene expression | Candidate for studies of inflammatory disease mechanisms |
| TNF | Pro-inflammatory cytokine whose production is regulated during immune responses | Widely studied in periodontal and inflammatory disease models |
| IL6 | Cytokine produced during immune responses and regulated by inflammatory pathways | Relevant to chronic inflammatory disease research |
| IL1B | Pro-inflammatory cytokine whose production is modulated during immune activation | Target for inflammatory disease and immune regulation studies |
| CXCL8 | Chemokine whose production is regulated in immune and inflammatory responses | Relevant to neutrophil recruitment and periodontal disease |
| MPL | Thrombopoietin receptor involved in thrombopoiesis and immune regulation in leishmaniasis | Links thrombopoiesis to cytokine regulation in infection |
| THPO | Thrombopoietin, a cytokine that influences thrombopoiesis and immune responses | Relevant to infection-associated cytokine regulation |
| HIF1A | Transcription factor responsive to redox and oxygen signals that modulates immune responses | Candidate for studies of redox regulation of cytokine production |
| NFE2L2 | Redox-sensitive transcription factor involved in immune response regulation | Relevant to oxidative control of cytokine production |
| MTOR | Kinase that integrates metabolic signals and influences immune cell cytokine production | Target for studies of mitochondrial regulation of immunity |
| PPARGC1A | Regulator of mitochondrial biogenesis that can influence immune cell function | Candidate for mitochondrial-immune interaction studies |
How Is regulation of cytokine production involved in immune response Regulated?
Regulation of cytokine production involved in immune response is controlled at multiple levels. Redox signaling modulates immune cell activation and cytokine production through oxidative modifications of signaling proteins. Post-transcriptional regulation by ZFP36 family RNA-binding proteins controls the stability of cytokine mRNAs and acts as a brake on inflammation. Mitochondria also contribute to immune regulation during bacterial infection, linking metabolic state to cytokine output. In addition, IL-10 production is regulated by cell-type-specific transcription factors and signaling pathways that determine the anti-inflammatory tone of the immune response.
regulation of cytokine production involved in immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL10 | Inflammatory and autoimmune conditions linked to impaired IL-10 production | IL10 knockout or reporter knock-in immune cells |
| ZFP36 | Inflammatory diseases driven by unstable cytokine mRNA regulation | ZFP36 knockout macrophages and cytokine stability assays |
| TNF | Periodontal disease and chronic inflammatory pathology | TNF knockout or overexpression in immune cell lines |
| IL21 | Viral infection outcomes and antiviral immunity | IL21 knockout or reporter knock-in T cells |
| MPL | Leishmaniasis and infection-associated thrombopoiesis | MPL knockout or knock-in hematopoietic models |
Periodontal disease
Inflammatory and immune pathways involving cytokine production are central to the pathogenesis of periodontal disease. Dysregulated regulation of cytokines such as TNF, IL6, IL1B, and CXCL8 contributes to tissue destruction in the periodontium. Studying GO:0002718 in this context helps identify regulatory nodes that could be targeted to reduce inflammatory damage.
Hypertension and innate immune activation
Innate immune responses in hypertension involve altered cytokine regulation, linking immune signaling to cardiovascular pathology. Cytokines produced by innate immune cells can promote vascular dysfunction and sustained inflammation. This makes GO:0002718 relevant to understanding how immune regulation influences blood pressure and cardiovascular risk.
Leishmaniasis and thrombopoiesis
Thrombopoiesis and cytokine regulation interact in leishmaniasis, where infection alters hematopoietic and immune responses. Cytokines such as thrombopoietin and related factors influence disease outcomes. Research on GO:0002718 in this setting can clarify how cytokine production is rewired during parasitic infection.
Viral infections and IL-21
Interleukin-21 production is regulated during viral infections and shapes antiviral immune responses. Dysregulated cytokine production can contribute to immunopathology or impaired viral clearance. GO:0002718 provides a framework for studying how IL-21 and other cytokines are controlled during viral challenge.
From regulation of cytokine production involved in immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for cytokine production? | CRISPR knockout in primary immune cells or cell lines |
| Does a specific point mutation alter cytokine regulation? | CRISPR point mutation knock-in at the endogenous locus |
| Does a disease-associated variant change cytokine output? | Knock-in of the variant allele followed by cytokine assays |
| Where and when is a cytokine regulatory protein expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a regulator suppress cytokine production? | CRISPR overexpression or cDNA overexpression model |
| Which regulatory networks control cytokine production genome-wide? | CRISPR library screening with cytokine readouts |
How to Study the regulation of cytokine production involved in immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Secreted cytokine protein levels | Quantifying cytokine production after immune activation |
| Intracellular cytokine staining | Cytokine production at single-cell level | Identifying cytokine-producing immune cell subsets |
| RNA-seq | Global mRNA expression changes | Discovering transcriptional regulators of cytokine production |
| mRNA stability assay | Half-life of cytokine transcripts | Studying ZFP36-mediated post-transcriptional control |
| Phospho-flow cytometry | Signaling pathway activation | Linking redox and immune signaling to cytokine production |
| CRISPR knockout screening | Gene requirement for cytokine production | Unbiased discovery of regulatory genes |
| Reporter knock-in imaging | Real-time cytokine promoter activity | Tracking cytokine regulation in live immune cells |
| Proteomics | Protein expression and modification | Identifying redox-sensitive regulators of immune responses |
Cytokine production assays
ELISA, Luminex, and intracellular cytokine staining are standard methods to quantify cytokine production from immune cells after activation. These assays measure the output of GO:0002718 and are used to compare wild-type and CRISPR-edited cells.
RNA-level analysis of cytokine regulation
RNA-seq and quantitative PCR measure cytokine mRNA levels and can distinguish transcriptional from post-transcriptional regulation. In ZFP36 studies, mRNA stability assays reveal how RNA-binding proteins control cytokine transcripts.
Protein and signaling analysis
Western blotting, immunoprecipitation, and phospho-flow cytometry assess signaling pathways that regulate cytokine production. These methods help identify redox-sensitive and mitochondrial-dependent regulatory inputs.
Functional genomics and CRISPR screening
CRISPR knockout and library screening enable unbiased discovery of genes that regulate cytokine production in immune cells. Coupling screens with cytokine readouts identifies positive and negative regulators within GO:0002718.
How CRISPR Can Be Used to Study GO:0002718 regulation of cytokine production involved in immune response
Knockout
CRISPR knockout of candidate genes such as IL10 or ZFP36 allows direct testing of whether a gene is required for regulated cytokine production in immune cells. Knockout models can reveal loss of negative feedback and excessive cytokine output.
Point Mutation
CRISPR point mutation knock-in can introduce disease-associated variants into endogenous cytokine regulatory genes to test their effect on cytokine production. This approach preserves native regulatory context and is ideal for functional interpretation of genetic variants.
Knock-in
Knock-in of reporter or epitope tags at cytokine loci enables tracking of cytokine production and regulatory protein localization in live cells. Tagged knock-in models are useful for imaging and biochemical studies of GO:0002718.
Overexpression
CRISPR-mediated overexpression or cDNA overexpression of regulators such as ZFP36 family proteins can test whether increased dosage suppresses cytokine production. Overexpression models complement knockout studies by revealing sufficiency of a regulator.
How EDITGENE Supports regulation of cytokine production involved in immune response Research
Researchers studying regulation of cytokine production involved in immune response-related genes often need to determine whether a candidate gene is causally involved in cytokine regulation or merely correlated with immune activation. CRISPR-based perturbation provides the causal evidence required for publication-grade conclusions, and EDITGENE offers end-to-end services to generate and characterize such models.
Contact EDITGENE today to design your custom CRISPR model for regulation of cytokine production involved in immune response research.
Frequently Asked Questions About regulation of cytokine production involved in immune response
What is GO:0002718 regulation of cytokine production involved in immune response?
GO:0002718 is a biological process term describing any mechanism that modulates the frequency, rate, or extent of cytokine production during an immune response.
What genes are involved in regulation of cytokine production involved in immune response?
Genes such as IL10, ZFP36, ZFP36L1, ZFP36L2, IL21, TNF, IL6, and IL1B are experimentally implicated in regulating cytokine production during immune responses.
Why is regulation of cytokine production important for immunity?
It ensures that cytokines are produced at the right time and amount to clear pathogens without causing excessive inflammation or tissue damage.
How is cytokine production regulated post-transcriptionally?
RNA-binding proteins of the ZFP36 family destabilize cytokine mRNAs and thereby limit inflammatory cytokine production.
What role does IL-10 play in cytokine regulation?
IL-10 is an anti-inflammatory cytokine whose regulated production is essential for limiting immune responses and preventing immunopathology.
How does redox signaling affect cytokine production?
Redox regulation of the immune response modulates signaling pathways that control cytokine production and inflammation.
Which diseases are linked to dysregulated cytokine production?
Periodontal disease, hypertension, leishmaniasis, and viral infections have all been linked to altered regulation of cytokine production.
How can CRISPR be used to study GO:0002718?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes that regulate cytokine production in immune cells.
What methods measure cytokine production in immune cells?
ELISA, intracellular cytokine staining, RNA-seq, and reporter assays are commonly used to measure cytokine production and its regulation.
What is the role of mitochondria in cytokine regulation?
Mitochondria contribute to immune response regulation during bacterial infection, linking metabolic state to cytokine production.
Conclusion
GO:0002718, regulation of cytokine production involved in immune response, is a central biological process that integrates transcriptional, post-transcriptional, redox, and metabolic inputs to shape immune outcomes. Its dysregulation is implicated in periodontal disease, hypertension, leishmaniasis, and viral infections, making it a high-value target for functional genomics. CRISPR-based knockout, knock-in, point mutation, and overexpression models provide the causal evidence needed to move from correlation to mechanism in cytokine regulation research.
References
- 1. Morris G et al.. 2022. Redox regulation of the immune response.. Cell Mol Immunol 19(10):1079-1101 PMID: 36056148
- 2. Saraiva M et al.. 2010. The regulation of IL-10 production by immune cells.. Nat Rev Immunol 10(3):170-81 PMID: 20154735
- 3. Cekici A et al.. 2014. Inflammatory and immune pathways in the pathogenesis of periodontal disease.. Periodontol 2000 64(1):57-80 PMID: 24320956
- 4. De Sanctis JB. 2022. Innate Immune Response in Hypertension.. Curr Pharm Des 28(36):2984-2990 PMID: 36154596
- 5. Mukherjee A et al.. 2021. Role of thrombopoiesis in leishmaniasis.. Cytokine 147:155310 PMID: 33127256
- 6. Khan S et al.. 2023. Role of mitochondria in regulating immune response during bacterial infection.. Int Rev Cell Mol Biol 374:159-200 PMID: 36858655
- 7. Asao H. 2021. Interleukin-21 in Viral Infections.. Int J Mol Sci 22(17) PMID: 34502427
- 8. Makita S et al.. 2021. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.. Front Immunol 12:711633 PMID: 34276705
